Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Braun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Braun is a nephrologist based in Cleveland, OH. He completed his medical education at Georgetown University School of Medicine and pursued several training programs, including residencies in Internal Medicine and a fellowship in Cardiovascular Disease. His research contributions include publications focusing on polycystic kidney disease, with noteworthy works published in important journals like the Clinical Journal of the American Society of Nephrology and Kidney International Reports. Dr. Braun was involved in clinical trials such as the Pilot Study of Rapamycin for treating Autosomal Dominant Polycystic Kidney Disease. He has received CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR in 2011 and 2013.
Education & Training
Ohio State University HospitalResidency, Gastroenterology, 2021 - 2027
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1965 - 1968
MedStar Health Georgetown UniversityFellowship, Cardiovascular Disease, 1962 - 1963- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1960 - 1962
Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1959 - 1960
Certifications & Licensure
OH State Medical License 1960 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
Publications & Presentations
PubMed
- 15 citationsVolume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.Kyongtae T Bae, Cheng Tao, Robert Feldman, Alan S L Yu, Vicente E Torres
Clinical Journal of the American Society of Nephrology. 2022-03-01 - 8 citationsPKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney N. Steele, Zhiying You, Berenice Gitomer, Godela Brosnahan, Kaleab Z. Abebe
Kidney International Reports. 2021-10-01 - 12 citationsPain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies.Kristen L. Nowak, Kaleigh Murray, Zhiying You, Berenice Gitomer, Godela Brosnahan
Kidney Medicine. 2021-04-24
Authored Content
- Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 2018
Press Mentions
2015 AST FAST DesigneesMay 21st, 2015
Going to the ASN 2018 Annual Meeting? Make Sure to Attend Our Cleveland Clinic SessionsOctober 24th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: